Single Potassium Channel Mutation Rewrites the Rules of a Rare Neurological Gene

A single letter change in a gene long associated with episodes of lost coordination has now been linked to something entirely different: autism spectrum disorder accompanied by a mild tremor, in a teenager who has never had a single seizure. The discovery, published in Annals of Clinical and Translational Neurology, centers on a novel variant in KCNA1, the gene encoding the Kv1.1 voltage-gated potassium channel, and it comes with a biophysical twist that has surprised researchers studying this family of channel proteins. Rather than simply silencing the channel or overactivating it, the mutation appears to do both at once, producing what scientists call a mixed loss-of-function and gain-of-function defect.

The Kv1.1 channel is one of the workhorses of the nervous system. Built from four identical subunits, each spanning the cell membrane six times, it opens and closes in response to changes in electrical voltage, allowing potassium ions to flow out of neurons and helping to repolarize action potentials. In doing so, it fine-tunes neuronal excitability and regulates the release of neurotransmitters at synapses throughout the central and peripheral nervous systems. When KCNA1 loses function, the classic result is episodic ataxia type 1, a rare disorder marked by recurrent bouts of unsteadiness and visible muscle rippling called myokymia, typically beginning in childhood. Over the years, however, the clinical picture has grown far messier, with KCNA1 variants also implicated in epilepsy, migraine, paroxysmal dyskinesia, hereditary spastic paraplegia, nystagmus, cataplexy, and even disturbances of magnesium metabolism.

Gain-of-function variants, by contrast, have been vanishingly rare. Before this report, only two had ever been described, both in patients with epilepsy. One, called A261T, sits in the S3 segment and was found in a person with fever-induced seizures, ataxia, and myokymia; the other, L296F, in the voltage-sensing S4 helix, caused severe drug-resistant epilepsy in an infant. What makes the new case remarkable is that the patient carries a KCNA1 variant yet presents with neither epilepsy nor ataxia. Instead, the 16-year-old boy has mild autism spectrum disorder, borderline intellectual functioning with a total IQ of 79, and a distal postural and action tremor affecting his hands and occasionally his feet.

The clinical story is strikingly subtle. The tremor was first noticed three to four years before assessment, has remained mild and non-disabling, and has actually improved since onset. Neurological examination was essentially normal: muscle tone, strength, coordination, and gait were intact, with no episodic ataxia, dysarthria, nystagmus, or myokymia. Electromyography of the right brachioradialis muscle found no myokymic discharges or repetitive activity, and a brain MRI showed normal cerebral and cerebellar structure with no atrophy. Language development had been delayed, with vocabulary limited to a handful of words before age three, and autism was formally diagnosed at age ten after difficulties with social interaction and reduced eye contact prompted a specialized assessment. There was no family history of tremor, epilepsy, ataxia, autism, or related neurological conditions.

Whole-exome sequencing revealed a heterozygous variant in KCNA1, designated c.1201G>A or p.(Ala401Thr), classified as likely pathogenic under American College of Medical Genetics criteria. No other potentially relevant variant was found. The mother tested negative for the variant, but the father had died roughly seven years earlier and no DNA sample was available, so a de novo occurrence cannot be confirmed and paternal inheritance with reduced penetrance cannot be excluded. The substitution, abbreviated A401T, replaces an alanine with a threonine at position 401, deep within the S6 transmembrane helix of the channel, immediately adjacent to the highly conserved Pro-Val-Pro motif, a hinge-like element critical to how the pore opens and closes. Sequence comparisons show this residue is strongly conserved across the entire Kv1 channel family, and structural modeling suggests the alanine normally forms a hydrogen bond with a neighboring valine that helps stabilize the helix.

To understand what the substitution actually does, the team turned to patch-clamp electrophysiology, the gold-standard technique for measuring the electrical currents that flow through individual ion channels. They expressed either normal Kv1.1, the A401T mutant, or a one-to-one mixture mimicking the patient’s heterozygous state in HEK293 cells, and then recorded the potassium currents. The results were unambiguous on one front: current amplitude collapsed. Cells expressing only A401T generated currents roughly tenfold smaller than normal, while the mixed channels produced only about 40 percent of wild-type current, 0.84 versus 2.10 nanoamperes at the test voltage. Western blot analysis hinted at a partial explanation, showing reduced Kv1.1 protein expression of 39 percent for the mutant alone and 24 percent under heterozygous conditions, though these differences did not reach statistical significance.

But the mutation also did something unexpected. Both A401T channels and the mixed WT-plus-mutant channels activated at voltages roughly 12 to 14 millivolts more negative than normal, a hyperpolarizing shift that means the channels open more readily, the hallmark of a gain of function. At the same time, the mutant channels activated more slowly than normal at every voltage tested, and both mutant and mixed channels showed slightly accelerated C-type inactivation, the slow process by which the pore shuts itself during prolonged activity. Recovery from inactivation, however, was unaffected. This combination, channels that open too easily but carry far less current and gate sluggishly, is precisely what defines a mixed loss-of-function and gain-of-function profile, a molecular signature previously unrecognized in KCNA1.

The authors propose that swapping alanine for the bulkier threonine perturbs the local hydrogen-bonding network and the conformational dynamics of the S6 helix, impairing the transitions between closed and open states that underlie channel gating. Because the patient carries only one mutant copy, functional channels in his cells are expected to be mosaics of wild-type and mutant subunits, and the reduced current in the co-expression experiments points to a dominant-negative effect, in which mutant subunits drag down the performance of their normal partners, although simple haploinsufficiency cannot be ruled out. How such a defect translates into autism and tremor rather than epilepsy remains an open question, but the answer is likely circuit-specific. Kv1.1 and its partner Kv1.2 regulate inhibitory signaling at cerebellar basket cell terminals, and their disruption derails Purkinje cell inhibition, producing ataxia in animal models. Mice lacking Kv1.1 develop seizures and die suddenly of epileptic death, while altered Kv1.1 function in interneurons has been tied to anxiety-like behaviors.

The researchers are careful about the limits of their work. The experiments were performed in a heterologous cell line that does not fully reproduce the subunit composition and regulatory environment of real neurons, no in vivo validation was carried out, and a single patient cannot establish that A401T is the sole cause of his autism. Still, the implications are considerable. No KCNA1 variant has ever been associated with autism spectrum disorder before, and the finding expands both the clinical and the functional spectrum of KCNA1-related disease. It also reinforces a growing theme in channelopathy research: that detailed biophysical characterization of each variant, distinguishing loss of function from gain of function, may ultimately guide precision therapies, since drugs that dampen channel activity would help patients with gain-of-function variants but could worsen disease in those whose channels have already lost it. For now, a single tremor in a teenager’s hands has revealed that one of neurology’s best-studied potassium channels still has secrets worth keeping.

Subject of Research: Functional characterization of a novel KCNA1 Kv1.1 potassium channel variant associated with autism spectrum disorder and tremor

Article Title: A Novel KCNA1 Variant in a Patient With Tremor and Autism Spectrum Disorder Causes Mixed LOF/GOF Defects of Kv1.1 Channels

Article References: Ortigoza‐Escobar, J. D., Marti‐Sánchez, L., Martorell, L., Dinoi, G., Buono, A. V., De Luca, A., Liantonio, A., & Imbrici, P. (2026). A Novel KCNA1 Variant in a Patient With Tremor and Autism Spectrum Disorder Causes Mixed LOF / GOF Defects of Kv1.1 Channels. Annals of Clinical and Translational Neurology, Article acn3.70536. https://doi.org/10.1002/acn3.70536

Image Credits: AI Generated

DOI: 10.1002/acn3.70536

Keywords: KCNA1, Kv1.1, potassium channel, autism spectrum disorder, tremor, channelopathy, patch-clamp electrophysiology, episodic ataxia, gain-of-function, loss-of-function, genetics, neurology